1. Gu M, Li A#, Mak W, Dong F, Xu N, Zhang J, Shi Y, Zheng N, Tang Z, He Q, Ruan C, Guo W, Xiang X, Wang C*, Han B*, Zhu X*.Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization.Front Pharmacol.2023.14.1089862.SCI |
2. Zhao L, Bo Q, Zhang Z, Chen Z, Wang Y, Zhang D, Li T, Yang N, Zhou Y*, Wang C*.Altered dynamic functional connectivity in early psychosis between the salience network and visual network.Neuroscience.2022.491.166-175.SCI |
3. He Y, Bo Q, Mao Z, Yang J, Liu M, Wang H, Kastin AJ, Pan W, Wang C*, Sun Z*.Reduced Serum Levels of Soluble Interleukin-15 Receptor α in Schizophrenia and Its Relationship to the Excited Phenotype.Front Psychiatry.2022.13.842003.SCI |
4. Chang Q, Li C, Zhang J*, Wang C*.Dynamic brain functional network based on EEG microstate during sensory gating in schizophrenia.J Neural Eng.2022.19(2).026007.SCI |
5. Zhang ZF, Bo QJ#, Li F, Zhao L, Gao P, Wang Y, Liu R, Chen XY, Wang CY*, Zhou Y*.Altered frequency-specific/universal amplitude characteristics of spontaneous brain oscillations in patients with bipolar disorder.Neuroimage Clin.2022.36.103207.SCI |
6. Zhao J, Lu XH, Liu Y, Wang N, Chen DY, Lin IA, Li XH*, Zhou FC*, Wang CY*.The Unique Contribution of Past Bullying Experiences to the Presence of Psychosis-Like Experiences in University Students.Front Psychiatry.2022.13.839630.SCI |
7. Lin B, Li XB#, Ruan S, Wu YX, Zhang CY, Wang CY*, Wang LB*.Convergent and divergent gray matter volume abnormalities in unaffected first-degree relatives and ultra-high risk individuals of schizophrenia.Schizophrenia (Heidelb).2022.8(1).55.SCI |
8. Zhang Z, Bo Q#, Li F, Zhao L, Wang Y, Liu R, Chen X, Wang C*, Zhou Y*.Altered effective connectivity among core brain networks in patients with bipolar disorder.J Psychiatr Res.2022.152.296-304.SCI |
9. Tian Q, Yang NB, Fan Y, Dong F, Bo QJ, Zhou FC, Zhang JC, Li L, Yin GZ*, Wang CY*, Fan M*.Detection of Schizophrenia Cases From Healthy Controls With Combination of Neurocognitive and Electrophysiological Features.Front Psychiatry.2022.13.810362.SCI |
10. Chang Q, Li C, Tian Q, Bo Q, Zhang J*, Xiong Y*, Wang C*.Classification of First-episode Schizophrenia, Chronic Schizophrenia and Healthy Control Based on Brain Network of Mismatch Negativity by Graph Neural Network.IEEE Trans Neural Syst Rehabil Eng.2021.29.1784-1794.SCI |
11. Sun Z, Zhao L, Bo Q, Mao Z, He Y, Jiang T, Li Y, Wang C*, Li R*.Brain-Specific Oxysterols and Risk of Schizophrenia in Clinical High-Risk Subjects and Patients With Schizophrenia.Front Psychiatry.2021.12.711734.SCI |
12. Bo Q, Mao Z#, Tian Q, Yang N, Li X, Dong F, Zhou F, Li L, Wang C*.Impaired Sensorimotor Gating Using the Acoustic Prepulse Inhibition Paradigm in Individuals at a Clinical High Risk for Psychosis.Schizophr Bull.2021.47(1).128-137.SCI |
13. Sun Z, Bo Q#, Mao Z, Li F, He F, Pao C, Li W, He Y, Ma X, Wang C*.Reduced Plasma Dopamine-β-Hydroxylase Activity Is Associated With the Severity of Bipolar Disorder: A Pilot Study.Front Psychiatry.2021.12.566091.SCI |
14. Li XB, Jiang WL#, Wen YJ, Wang CM, Tian Q, Fan Y, Yang HB*, Wang CY*.The attenuated visual scanpaths of patients with schizophrenia whilst recognizing emotional facial expressions are worsened in natural social scenes.Schizophr Res.2020.220.155-163.SCI |
15. Liu S, Tian M#, He F#, Li J#, Xie H#, Liu W, ……, Xing J, Wang C*, Yu F*, Guan JS*.Mutations in ASH1L confer susceptibility to Tourette syndrome.Mol Psychiatry.2020.25(2).476-490.SCI |
16. Wang L, Li F#, Mitchell PB, Wang CY*, Si TM*.Striatal Resting-State Connectivity Abnormalities Associated With Different Clinical Stages of Major Depressive Disorder.J Clin Psychiatry.2020.81(2).19m12790.SCI |
17. Luo Y, Tian Q, Wang C, Zhang K*, Wang C*, Zhang J*.Biomarkers for Prediction of Schizophrenia: Insights From Resting-State EEG Microstates.IEEE Access.2020.8.213078-213093.SCI |
18. Chen S, Tian L, Chen N, Xiu MH, Wang ZR, Wang YC, Tan YL*, Wang CY*.More dampened monocytic Toll-like receptor 4 response to lipopolysaccharide and its association with cognitive function in Chinese Han first-episode patients with schizophrenia.Schizophr Res.2019.206.300-306.SCI |
19. Chen X, Li X#, Yan T, Dong Q, Mao Z, Wang Y, Yang N, Zhang Q, Zhao W, Zhai J, Chen M, Du B, Deng X, Ji F, Xiang YT, Song J, Wu H, Dong Q, Chen C, Wang C*, Li J*.Network functional connectivity analysis in individuals at ultrahigh risk for psychosis and patients with schizophrenia.Psychiatry Res: Neuroimaging.2019.290.51-57.SCI |
20. Chang Q, Liu M, Tian Q, Wang H, Luo Y, Zhang J*, Wang C*.EEG-Based Brain Functional Connectivity in First-Episode Schizophrenia Patients, Ultra-High-Risk Individuals, and Healthy Controls During P50 Suppression.Front Hum Neurosci.2019.13.379.SCI |
21. Li XB, Wang LB#, Xiong YB, Bo QJ, He F, Li F, Hou WP, Wen YJ, Wang XQ, Yang NB, Mao Z, Dong QH, Zhang FF, Yang R, Wang D, Xiang YT, Zhu YY, Tang YL, Yang Z, Wang CY*.Altered resting-state functional connectivity of the insula in individuals with clinical high-risk and patients with first-episode schizophrenia.Psychiatry Res.2019.282.112608.SCI |
22. Luo Y, Zhang J*, Wang C, Zhao X, Chang Q, Wang H, Wang C*.Discriminating schizophrenia disease progression using a P50 sensory gating task with dense-array EEG, clinical assessments, and cognitive tests.Expert Rev Neurother.2019.19(5).459-470.SCI |
23. Xiong YB, Bo QJ, Wang CM, Tian Q, Liu Y, Wang CY*.Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia.Front. Behav. Neurosci.2019.13.37.SCI |
24. Bo Q, Dong F#, Li X, Li F, Li P, Yu H, He F, Zhang G, Wang Z, Ma X, Wang C*.A comparison of cognitive performance in bipolar disorder, major depressive disorder, unaffected first-degree relatives, and healthy controls.Psychiatry Clin Neurosci.2019.73(2).70-76.SCI |
25. Wen YJ, Li XB, Zhao XX, Wang XQ, Hou WP, Bo QJ, Zheng W, Pao C, Tan T, Wang CY*.The effect of left-behind phenomenon and physical neglect on behavioral problems of children.Child Abuse Negl.2019.88.144-151.SCI |
26. Huang J, Zhou FC#, Guan B, Zhang N, Wang A, Yu P, Zhou L, Wang CY*, Wang C*.Predictors of Remission of Early-Onset Poststroke Depression and the Interaction Between Depression and Cognition During Follow-Up.Front. Psychiatry.2019.9.738.SCI |
27. Li XB, Bo QJ, Tian Q, Yang NB, Mao Z, Zheng W, Wen YJ, Wang CY*.Impact of childhood trauma on sensory gating in patients with first-episode schizophrenia.BMC Psychiatry.2018.18(1).258.SCI |
28. Li A, Ji S#, Yue W, Yan H, Dong F, Ruan C, Li W, Lu W, Zhang D*, Wang C*.Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia.BMJ Open.2018.8(8).e020070.SCI |
29. Bo Q, Mao Z#, Tian Q, Wen Y, Dong F, Li X, Wang Z, Ma X, Wang C*.Deficits of perceived spatial separation-induced prepulse inhibition in patients with bipolar disorder compared to healthy controls.J Affect Disord.2018.240.63-71.SCI |
30. Li XB, Zheng W#, Ning YP#, Cai DB, Yang XH, Ungvari GS, Ng CH, Wang CY*, Xiang YT*.Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review..Pharmacopsychiatry.2018.51(3).100-104.SCI |
31. Zheng H, Li F, Bo Q, Li X, Yao L, Yao Z, Wang C*, Wu X*.The dynamic characteristics of the anterior cingulate cortex in resting-state fMRI of patients with depression.J Affect Disord.2018.227.391-397.SCI |
32. Li X, Tian Q, Bo Q, Zhang G, Zheng W, Wen Y, Tang Y, Wang C*.Impact of childhood trauma on sensorimotor gating in Chinese patients with chronic schizophrenia.Psychiatry Res.2018.263.69-73.SCI |
33. Li XB, Bo QJ#, Zhang GP, Zheng W, Wang ZM, Li AN, Tian Q, Liu JT, Tang YL, Wang CY*.Effect of childhood trauma on cognitive functions in a sample of Chinese patients with schizophrenia.Compr Psychiatry.2017.76.147-152.SCI |
34. Yang NB, Tian Q#, Fan Y, Bo QJ, Zhang L, Li L, Wang CY*.Deficits of perceived spatial separation induced prepulse inhibition in patients with schizophrenia: relationships to symptoms and neurocognition.BMC Psychiatry.2017.17(1).135.SCI |
35. Zhou FC, Wang CY#, Ungvari GS, Ng CH, Zhou Y, Zhang L, Zhou J, Shum DH, Man D, Liu DT, Li J, Xiang YT*.Longitudinal changes in prospective memory and their clinical correlates at 1-year follow-up in first-episode schizophrenia.PLoS One.2017.12(2).e0172114.SCI |
36. Bo Q, Li F#, Li X, Wang Z, Dong F, He F, Li A, Ma X, Wang C*.Symptomatic remission in schizophrenia: Results from a risperidone maintenance treatment study.Psychiatry Res.2017.258.289-294.SCI |
37. Tang J, Fan Y#, Li H#, Xiang Q, Zhang DF, Li Z, He Y, Liao Y, Wang Y, He F, Zhang F, Shugart YY, Liu C, Tang Y*, Chan RCK*, Wang CY*, Yao YG*, Chen X*.Whole-genome sequencing of monozygotic twins discordant for schizophrenia indicates multiple genetic risk factors for schizophrenia.J Genet Genomics.2017.44(6).295-306.SCI |
38. Ji S, Shang D, Wu K, Li A, Li X, Deng C, Li L, Zhou T, Wang C*, Lu W*.Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients.Int J Clin Pharmacol Ther.2016.54(5).378-389.SCI |
39. Bo QJ, Wang ZM#, Li XB, Ma X, Wang CY*, de Leon J.Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review.Psychiatry Res.2016.237.257-63.SCI |
40. Bo QJ, Li XB, Wang ZM, Li AN, Ma X, Wang CY*.Extrapyramidal Symptoms During Risperidone Maintenance Treatment in Schizophrenia: A Prospective, Multicenter Study.J Clin Psychopharmacol.2016.36(2).125-129.SCI |
41. Ruan CJ, Li AN#, Dong F, Zhai YM, Li WB, Wang CY*, de Leon J.Single- and Multiple-Dose Milnacipran Pharmacokinetics in Healthy Han Chinese Volunteers.Clin Pharmacokinet.2016.55(7).889-896.SCI |
42. Bo Q, Dong F, Li X, Wang Z, Ma X, Wang C*.Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia.BMC Psychiatry.2016.16(1).386.SCI |
43. Ji S, Li A#, Wu K, Deng C, Dong F, Li L, Zhou T, Yue W, Wang CY*, Lu W*.Brief Questionnaire Derived from PANSS Using a General Probability Model to Assess and Monitor the Clinical Features of Schizophrenia.Pharmacopsychiatry.2016.49(3).117-123.SCI |
44. Man SC, Li XB#, Wang HH, Yuan HN, Wang HN, Zhang RG, Tan QR, Wong HK, McAlonan GM, Wang CY*, Zhang ZJ*.Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Women With Schizophrenia: A Randomized Controlled Trial.J Clin Psychopharmacol.2016.36(6).572-579.SCI |